Stephanie Kuku
Stephanie leads Scientific Affairs for Conceivable Life Sciences, a start-up using robotics, machine vision and AI to automate the IVF laboratory. She serves as a Board trustee and on the Investment Committee of the King's Fund, and on the Health Advisory Board of Equinox. Stephanie served as Senior Advisor in Clinical AI at the World Health Organization's Department of Digital Health & Innovation. She was a Senior Consultant at Hardian Health, a leading consultancy in health technology and artificial intelligence, leading deep due diligence and validation strategy for over 50 AI & Deeptech startups. Her expertise lies at intersection of scientific, product, regulatory and go-to-market strategy in health-tech, biotech and techbio.
With a background as an OBGYN and surgical oncologist, she spent over 15 years engaged in clinical practice and research at Britain's National Health Service and HCA Healthcare. During her clinical career Stephanie sat on the council of the British Gynecological Cancer Society and was awarded numerous international travelling fellowships including to Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France.
She was awarded a Doctorate in Clinical Research at UCL (Oncology) where she remains an Honorary Senior Research Fellow at the Institute of Women's Health and is actively involved in AI research projects.
-
11-Jun-2024Headline KeynotesFireside Chat: The Power of AI to Transform Healthcare